Introduction Rheumatoid arthritis is a chronic systemic autoimmune disease, which affects approximately 1% of the total population and can lead to severe joint dysfunction and disability (1). Despite of the fact that there are more and more available drugs in the treatment (from conventional synthetic disease-modifying antirheumatic drugs to biological therapies or Janus-kinase inhibitors), there is still a significant proportion of patients who do not respond well to recent therapies (2).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Serena Bugatti
Transient monoarthritis and psoriatic skin lesions following COVID-19
Ludovico De Stefano1,2, Silvia Rossi1, http://orcid.org/0000-0001-8263-3925Carlomaurizio Montecucco1,2, http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2 1 Division of Rheumatology, IRCCS S Matteo, Pavia, Italy 2 Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy Correspondence to Dr Ludovico De Stefano, Division of Rheumatology, IRCCS S Matteo, Pavia 27100, Italy; ludovico.destefano01{at}universitadipavia.it Statistics from Altmetric.com Request...
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
Abstract : Rheumatoid arthritis (RA) and diabetes mellitus (DM) are linked by underlying inflammation influencing their development and progression. Nevertheless, the profile of diabetic RA patients and the impact of DM on RA need to be elucidated.
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis
http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Ludovico De Stefano1,2, Bernardo D’Onofrio1,2, Andrea Nicrosini1,2, Eleonora Mauric1,2, Michele di Lernia1,2, Garifallia Sakellariou2,3, http://orcid.org/0000-0003-1471-6467Ennio Giulio Favalli4,5, Antonio Manzo1,2, Roberto Caporali4,5, http://orcid.org/0000-0001-8263-3925Carlomaurizio Montecucco1,2 1 Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy 2 Department of Internal Medicine and Therapeutics,...
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Ludovico De Stefano1,2, Bernardo D’Onofrio1,2, Andrea Nicrosini1,2, Eleonora Mauric1,2, Michele di Lernia1,2, Garifallia Sakellariou2,3, http://orcid.org/0000-0003-1471-6467Ennio Giulio Favalli4,5, Antonio Manzo1,2, Roberto Caporali4,5,...
Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis
Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Ludovico De Stefano1,2, http://orcid.org/0000-0003-1471-6467Ennio Giulio Favalli3, Roberto Caporali3,4, Carlomaurizio Montecucco1,2 1 Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Lombardia, Italy 2 Division of Rheumatology, IRCCS S Matteo,...
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis Free http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Ludovico De Stefano1,2, Silvia Balduzzi1, Maria Immacolata Greco1, Terenzj Luvaro1, Irene Cassaniti3,4, Laura Bogliolo1, Iolanda Mazzucchelli2, Bernardo D’Onofrio1,2, Michele di Lernia1,2, Eleonora Mauric1,2, Daniele Lilleri3, Fausto...
Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’
Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’ Free http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Silvia Balduzzi1, Ludovico De Stefano1,2, Antonio Manzo1,2, Blerina Xoxi1, Laura Bogliolo1, http://orcid.org/0000-0002-1800-6772Sara Monti1,2, http://orcid.org/0000-0002-6383-8236Paolo Delvino1,2, http://orcid.org/0000-0001-8263-3925Carlomaurizio Montecucco1,2 1 Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia,...
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis Free http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Ludovico De Stefano1,2, Silvia Balduzzi1, Maria Immacolata Greco1, Terenzj Luvaro1, Irene Cassaniti3,4, Laura Bogliolo1, Iolanda Mazzucchelli2, Bernardo D’Onofrio1,2, Michele di Lernia1,2, Eleonora Mauric1,2, Daniele Lilleri3, Fausto...
Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’
Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’ Free http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Silvia Balduzzi1, Ludovico De Stefano1,2, Antonio Manzo1,2, Blerina Xoxi1, Laura Bogliolo1, http://orcid.org/0000-0002-1800-6772Sara Monti1,2, http://orcid.org/0000-0002-6383-8236Paolo Delvino1,2, http://orcid.org/0000-0001-8263-3925Carlomaurizio Montecucco1,2 1Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia,...
Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’
Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’ Free http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Silvia Balduzzi1, Ludovico De Stefano1,2, Antonio Manzo1,2, Blerina Xoxi1, Laura Bogliolo1, http://orcid.org/0000-0002-1800-6772Sara Monti1,2, http://orcid.org/0000-0002-6383-8236Paolo Delvino1,2, http://orcid.org/0000-0001-8263-3925Carlomaurizio Montecucco1,2 1Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia,...
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis
Research article Open Access Published: 30 December 2020 Ennio Giulio Favalli ORCID: orcid.org/0000-0003-1471-64671 na1, Serena Bugatti2,3 na1, Catherine Klersy4, Martina Biggioggero1, Silvia Rossi2, Orazio De Lucia1, 2, Antonella Murgo1, Silvia Balduzzi2, Roberto Caporali1,5 na1 & 2,3 na1 Arthritis Research & Therapy volume 22, Article number: 290 (2020) Cite this article Abstract Background Prevalence and outcomes of coronavirus disease (COVID)-19 in relation to immunomodulatory medications...
Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis
Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis Free http://orcid.org/0000-0002-5396-7077Serena Bugatti1,2, Ludovico De Stefano1,2, http://orcid.org/0000-0003-1471-6467Ennio Giulio Favalli3, Roberto Caporali3,4, Carlomaurizio Montecucco1,2 1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Lombardia, Italy 2Division of Rheumatology, IRCCS S Matteo,...
Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreate
We read with great interest the article about the relationship between anti-citrullinated protein antibodies (ACPA), rheumatoid factor (RF) and systemic bone loss in 155 patients with early untreated rheumatoid arthritis (RA), published recently in Arthritis Research & Therapy [1]. The work is really interesting since it shows the association of ACPA with low bone mass in both lumbar spine and total hip in patients with early RA [1].
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Serena
Contact Serena, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack